Created at Source Raw Value Validated value
Nov. 26, 2021, 10:30 p.m. oms

<br/ > Severe disease (pneumonia with SpO2 <90% or respiratory rate >30/minute or severe respiratory distress) or critical illness (signs of shock, sepsis, multi-organ failure. <br/ >Chronic liver disease ((e.g., acute hepatitis, chronic active hepatitis, cirrhosis) or ALAT > 3 x ULN. <br/ >Chronic kidney disease (eGFR <30 mL/min/1.73m2). <br/ >History of intracranial bleeding in the last 3 months. <br/ >Bleeding diathesis, active peptic ulcer disease. <br/ >Pregnancy or first postpartum week. <br/ >Refractory hypertension (SBP >180 mmHg). <br/ >Any other contraindication listed in the local labelling of enoxaparin and rivaroxaban

<br/ > Severe disease (pneumonia with SpO2 <90% or respiratory rate >30/minute or severe respiratory distress) or critical illness (signs of shock, sepsis, multi-organ failure. <br/ >Chronic liver disease ((e.g., acute hepatitis, chronic active hepatitis, cirrhosis) or ALAT > 3 x ULN. <br/ >Chronic kidney disease (eGFR <30 mL/min/1.73m2). <br/ >History of intracranial bleeding in the last 3 months. <br/ >Bleeding diathesis, active peptic ulcer disease. <br/ >Pregnancy or first postpartum week. <br/ >Refractory hypertension (SBP >180 mmHg). <br/ >Any other contraindication listed in the local labelling of enoxaparin and rivaroxaban

Nov. 13, 2021, 5:33 p.m. oms

N/A

N/A

Sept. 8, 2021, 1:30 a.m. oms

<br/ > Severe disease (pneumonia with SpO2 <90% or respiratory rate >30/minute or severe respiratory distress) or critical illness (signs of shock, sepsis, multi-organ failure. <br/ >Chronic liver disease ((e.g., acute hepatitis, chronic active hepatitis, cirrhosis) or ALAT > 3 x ULN. <br/ >Chronic kidney disease (eGFR <30 mL/min/1.73m2). <br/ >History of intracranial bleeding in the last 3 months. <br/ >Bleeding diathesis, active peptic ulcer disease. <br/ >Pregnancy or first postpartum week. <br/ >Refractory hypertension (SBP >180 mmHg). <br/ >Any other contraindication listed in the local labelling of enoxaparin and rivaroxaban

<br/ > Severe disease (pneumonia with SpO2 <90% or respiratory rate >30/minute or severe respiratory distress) or critical illness (signs of shock, sepsis, multi-organ failure. <br/ >Chronic liver disease ((e.g., acute hepatitis, chronic active hepatitis, cirrhosis) or ALAT > 3 x ULN. <br/ >Chronic kidney disease (eGFR <30 mL/min/1.73m2). <br/ >History of intracranial bleeding in the last 3 months. <br/ >Bleeding diathesis, active peptic ulcer disease. <br/ >Pregnancy or first postpartum week. <br/ >Refractory hypertension (SBP >180 mmHg). <br/ >Any other contraindication listed in the local labelling of enoxaparin and rivaroxaban